Adaptimmune Ther ADR (ADAP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
Sales | 1,193 | 502 | 761 | 728 | 237 |
Gross Profit | 1,193 | 502 | 761 | 728 | 237 |
Operating Expenses | 37,068 | 30,755 | 30,525 | 31,083 | 40,358 |
Operating Income | -35,875 | -30,253 | -29,764 | -30,355 | -40,121 |
Other Income | 458 | 398 | 1,667 | 1,079 | 906 |
Pre-tax Income | -35,417 | -29,855 | -28,097 | -29,276 | -39,215 |
Income Tax | 15 | 25 | 70 | 88 | 87 |
Net Income Continuous | -35,432 | -29,880 | -28,167 | -29,364 | -39,302 |
Net Income | $-35,432 | $-29,880 | $-28,167 | $-29,364 | $-39,302 |
EPS Basic Total Ops | -0.24 | -0.22 | -0.23 | -0.30 | -0.36 |
EPS Basic Continuous Ops | -0.23 | -0.22 | -0.23 | -0.28 | -0.37 |
EPS Diluted Total Ops | -0.24 | -0.22 | -0.23 | -0.30 | -0.36 |
EPS Diluted Continuous Ops | -0.23 | -0.22 | -0.23 | -0.28 | -0.37 |
EBITDA(a) | $-31,509 | $-28,381 | $-28,053 | $-28,262 | $-38,179 |